Evidence map

ReviewCancer prevention research (Philadelphia, Pa.)2020

The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions.

Scott D Siegel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

25 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32132120